EDIT vs BEAM
EDIT 与 BEAM 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | EDITEDITAS MEDICINE, INC. | BEAMBeam Therapeutics Inc. |
|---|---|---|
| 市值 | $401.61M | $2.78B |
| 市净率 | — | 2.92 |
| 市销率 | 10.0x | 19.8x |
| 营收 | — | $146.64M(TTM) |
| 营收同比增长 | 25.4% | 120.0% |
| 净利润 | — | -$108.35M(TTM) |
| 净利同比增长 | 32.5% | 78.8% |
| 每股收益(稀释) | — | $-0.88(TTM) |
| 息税前利润率 | -394.9% | -274.6% |
| 净资产收益率 | -152.0% | -8.4% |
| 投入资本回报率 | — | -45.7% |
| 一年总回报 | -14.1% | +10.4% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:EDIT vs BEAM
| 指标 | EDIT | BEAM |
|---|---|---|
| 期末价值 | $932 | $14.3K |
| 总回报 | -90.7% | +43.0% |
| 年化收益 (CAGR) | -29.7% | +5.5% |
| 波动率 | 92.2% | 79.6% |
| 夏普比率 | 0.01 | 0.41 |
| 索提诺比率 | 0.02 | 0.63 |
| 最大回撤 | -98.9% | -89.1% |
基于 1695 个共同交易日,2020-02-06 → 2026-11-03 · 无风险利率 4.21%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)